{
  "id": 13970487,
  "title": "This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock",
  "url": "https://urgent.news/2026/10/12/this-drug-combination-for-eli-lilly-generated-significantly-more",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-12T12:59:02.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/12/this-drug-combination-for-eli-lilly-generated-significantly-more-weight-loss-than-just-zepbound-but-discontinuation-rates-were-also-far-higher-here-s-what-this-could-mean-for-the-stock/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "Eli Lilly isn't content with the success of its current GLP-1 drugs; it's on the hunt for even better weight loss solutions.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock",
        "url": "https://urgent.news/2026/10/12/this-drug-combination-for-eli-lilly-generated-significantly-more-13971539",
        "published": "2026-10-12T13:19:02.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}